83 FR 62875 - Eunice Kennedy Shriver National Institute of Child Health & Human Development; Notice of Closed Meeting
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health Federal Register Volume 83, Issue 234 (December 6, 2018)
National Institutes of Health
Federal Register Volume 83, Issue 234 (December 6, 2018)
| Page Range | 62875-62876 | |
| FR Document | 2018-26385 |
[Federal Register Volume 83, Number 234 (Thursday, December 6, 2018)] [Notices] [Pages 62875-62876] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2018-26385] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Eunice Kennedy Shriver National Institute of Child Health & Human Development; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections, as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Child Health and Human Development Initial Review Group Biobehavioral and Behavioral Sciences Subcommittee. Date: February 11-12, 2019. Time: 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Residence Inn Bethesda, 7335 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Bradley Monroe Cooke, 6710 B Rockledge Drive, Bethesda, Maryland 20892, 703.292.8460, [email protected]. (Catalogue of Federal Domestic Assistance Program Nos. 93.864, Population Research; 93.865, Research for Mothers and Children; 93.929, Center for Medical Rehabilitation Research; 93.209, Contraception and Infertility Loan Repayment Program, National Institutes of Health, HHS) [[Page 62876]] Dated: November 29, 2018. Ronald J. Livingston, Jr., Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2018-26385 Filed 12-4-18; 8:45 am] BILLING CODE 4140-01-P
![Federal Register / Vol. 83, No. 234 / Thursday, December 6, 2018 / Notices 62875
DEPARTMENT OF HEALTH AND Ophthalmol. Vis. Sci. 56(3):1678, 2015 Suspension, 2 CFR part 180 (collectively
HUMAN SERVICES Mar 9. the ‘‘Debarment Regulations’’) for a
• J. Control. Release 172(3):1151–60, period of three (3) years beginning on
Office of the Secretary 2013 (hereafter referred to as ‘‘J. Control. November 13, 2018;
Release 2013’’). Retracted in: J. Control. (2) to exclude himself from serving in
Findings of Research Misconduct Release 237:186, 2016 Sep 10. any advisory capacity to PHS including,
AGENCY: Office of the Secretary, HHS. • Int. J. Pharm. 434: 140–147, 2012 but not limited to, service on any PHS
(hereafter referred to as ‘‘Int. J. Pharm. advisory committee, board, and/or peer
ACTION: Notice.
2012’’). Retracted (no date provided by review committee, or as a consultant for
SUMMARY: Findings of research the journal for the retraction notice). a period of three (3) years beginning on
misconduct have been made on the part • Mol. Pharm. 9:605–614, 2012 November 13, 2018; and
of Rajendra Kadam, former Ph.D. (hereafter referred to as ‘‘Mol. Pharm. (3) as a condition of the Agreement,
student in pharmaceutical sciences, 2012’’). Retracted in: Mol. Pharm. 12(7): to request that the following paper be
University of Colorado, Denver (UCD) 2558, 2015 July 6. retracted:
(Respondent). Mr. Kadam engaged in • J. Pharmacol. Exp. Ther. 332:1107– • Mol. Vis. 19:1198–1210, 2013.
research misconduct in research 1120, 2010 (hereafter referred to as ‘‘J. Wanda K. Jones,
supported by National Eye Institute Pharmacol. Exp. Ther. 2010’’). Retracted Interim Director, Office of Research Integrity.
(NEI), National Institutes of Health in: J. Pharmacol. Exp. Ther. 352(2):326,
[FR Doc. 2018–26379 Filed 12–4–18; 8:45 am]
(NIH), grants R01 EY018940, R01 2015 Feb.
EY017533, R24 EY017045, and RC1 • Mol. Vis. 19:1198–1210, 2013 BILLING CODE 4150–31–P
EY020361. The administrative actions, (hereafter referred to as ‘‘Mol. Vis.
including debarment for a period of 2013’’).
DEPARTMENT OF HEALTH AND
three (3) years, were implemented • Curr. Pharm. Biotechnol. 12(2):285–
HUMAN SERVICES
beginning on November 13, 2018, and 292, 2011 (hereafter referred to as ‘‘Curr.
are detailed below. Pharm. Biotechnol. 2011’’). Erratum in: National Institutes of Health
Curr. Pharm. Biotechnol. 17(9):846,
FOR FURTHER INFORMATION CONTACT:
2016 Jun 6.1 Eunice Kennedy Shriver National
Wanda K. Jones, Dr.P.H., Interim Specifically, Respondent falsified data Institute of Child Health & Human
Director, Office of Research Integrity, included in: Development; Notice of Closed
1101 Wootton Parkway, Suite 750, • Figures 3.10 and 3.11 of Meeting
Rockville, MD 20852, (240) 453–8200. respondent’s thesis (also included as
SUPPLEMENTARY INFORMATION: Notice is Figures 10 and 11 in Drug Metab. Pursuant to section 10(d) of the
hereby given that the Office of Research Disposal. 2013). Federal Advisory Committee Act, notice
Integrity (ORI) has taken final action in • Figures 5.2–5.7 of respondent’s is hereby given of the following
the following case: thesis. meeting.
Rajendra Kadam, University of • Figures 4.4–4.7 of respondent’s The meeting will be closed to the
Colorado, Denver: Based on an thesis (also included as Figures 4–7 of public in accordance with the
investigation conducted by UCD, the Mol. Pharm. 2013). provisions set forth in sections, as
Respondent’s admission, and analysis • Figures 7.4, 7.5, and 7.7 of amended. The grant applications and
conducted by ORI in its oversight respondent’s thesis (also included as the discussions could disclose
review, ORI found that Mr. Rajendra Figures 1–5, 7, and 8 and summarized confidential trade secrets or commercial
Kadam, former Ph.D. student in in Tables 2 and 3 of IOVS 2011). property such as patentable material,
pharmaceutical sciences, UCD, engaged • Figure 6 of J. Control. Release 2013. and personal information concerning
in research misconduct in research • Figures 6–7 of Mol. Vis. 2013. individuals associated with the grant
supported by NEI, NIH, grants R01 • Figure 3 in Int. J. Pharm. 2012. applications, the disclosure of which
EY018940, R01 EY017533, R24 • Figures 3 and 5–7 in Mol. Pharm. would constitute a clearly unwarranted
EY017045, and RC1 EY020361. 2012. invasion of personal privacy.
ORI found that Respondent engaged • Figure 6C in Curr. Pharm. Name of Committee: National
in research misconduct by knowingly Biotechnol. 2011. Institute of Child Health and Human
and intentionally falsifying and/or • Tables 3–5 and Figures 1–5 in J. Development Initial Review Group
fabricating data by manipulating LC– Pharmacol. Exp. Ther. 2010. Biobehavioral and Behavioral Sciences
MS/MS peak area data to reduce Mr. Kadam entered into a Voluntary Subcommittee.
variability and/or alter statistical Exclusion Agreement (Agreement) and Date: February 11–12, 2019.
significance for twenty-six (26) figures voluntarily agreed: Time: 8:00 a.m. to 5:00 p.m.
and five (5) tables in his Ph.D. thesis (1) To exclude himself from any Agenda: To review and evaluate grant
and in the following nine (9) published contracting or subcontracting with any applications.
papers: agency of the United States Government Place: Residence Inn Bethesda, 7335
• Drug Metab. Dispos. 41:466–474, and from eligibility for or involvement Wisconsin Avenue, Bethesda, MD
2013 (hereafter referred to as ‘‘Drug in nonprocurement programs of the 20814.
Metab. Dispos. 2013’’). Retracted in: United States Government referred to as Contact Person: Bradley Monroe
Drug Metab. Dispos. 43(2):234, 2015 ‘‘covered transactions’’ pursuant to Cooke, 6710 B Rockledge Drive,
HHS’ Implementation (2 CFR part 376) Bethesda, Maryland 20892,
khammond on DSK30JT082PROD with NOTICES
Feb.
• Mol. Pharm. 10:2350–2361, 2013 of OMB Guidelines to Agencies on 703.292.8460, brad.cooke@nih.gov.
(hereafter referred to as ‘‘Mol. Pharm. Governmentwide Debarment and (Catalogue of Federal Domestic Assistance
Program Nos. 93.864, Population Research;
2013’’). Retracted in: Mol. Pharm. 93.865, Research for Mothers and Children;
1 While this publication does not cite U.S. Public
12(7):2559, 2015 July 6. 93.929, Center for Medical Rehabilitation
Health Service (PHS) funding in its
• Invest. Ophthalmol. Vis. Sci. acknowledgements, Mr. Kadam was funded through Research; 93.209, Contraception and
52(8):5387–99, 2011 (hereafter referred his advisor’s NIH funding while performing these Infertility Loan Repayment Program, National
to as ‘‘IOVS 2011’’). Retracted in: Invest. experiments. Institutes of Health, HHS)
VerDate Sep<11>2014 20:35 Dec 04, 2018 Jkt 247001 PO 00000 Frm 00043 Fmt 4703 Sfmt 4703 E:\FR\FM\06DEN1.SGM 06DEN1](https://thefederalregister.org/doc/83_FR_63109/page/1.svg)
![62876 Federal Register / Vol. 83, No. 234 / Thursday, December 6, 2018 / Notices
Dated: November 29, 2018. recommendations that the Committee We will consider applications for the
Ronald J. Livingston, Jr., makes to the Secretary. In addition, the following four positions that will be
Program Analyst, Office of Federal Advisory committee may be given special vacant on June 1, 2019. To be eligible,
Committee Policy. assignments by the Secretary and may you must have the experience listed for
[FR Doc. 2018–26385 Filed 12–4–18; 8:45 am] conduct studies, inquiries, workshops, the applicable membership position:
BILLING CODE 4140–01–P and fact finding in consultation with (1) One position for a member who
individuals and groups in the private serves as a representative of merchant
sector and with State or local
marine engineering officers. To be
DEPARTMENT OF HEALTH AND governments.
eligible, you must be licensed as either
HUMAN SERVICES DATES: Completed applications should a limited chief engineer or a designated
National Institutes of Health be submitted to the U.S. Coast Guard on duty engineer;
or before February 4, 2019. (2) One position for a member who
National Institute of Diabetes and ADDRESSES: Applicants should send a serves as a representative of qualified
Digestive and Kidney Diseases; cover letter expressing interest in an members of the engine department. To
Cancellation of Meeting appointment to the Merchant Marine be eligible, you must hold a current
Personnel Advisory Committee that merchant mariner credential with an
Notice is hereby given of the
identifies the applicant’s preferred engineering rating endorsement;
cancellation of the National Institute of
membership category along with a
Diabetes and Digestive and Kidney (3) One position for a member who
resume detailing the applicant’s
Diseases Special Emphasis Panel, serves as a representative of shipping
experience by one of the following
December 6, 2018, 6:00 p.m. to companies employed in ship operation
methods:
December 7, 2018, 5:00 p.m., Residence management. To be eligible, you must
• By Email: davis.j.breyer@uscg.mil,
Inn Arlington Pentagon City, 550 Army show that you have significant
(preferred) Subjectline: The Merchant
Navy Drive, Arlington, VA, 22202 knowledge and experience of shipping
Marine Personnel Advisory Committee;
which was published in the Federal companies and ship operation
• By Fax: 202–372–8382 ATTN: Mr.
Register on October 26, 2018, FR Doc. management; and
Davis J. Breyer, Alternate Designated
23393.
This meeting has been cancelled and Federal Officer; or (4) One position for a member who
will be rescheduled. • By Mail: Mr. Davis J. Breyer, serves as a representative of the state
Alternate Designated Federal Officer of maritime academies, as identified in 46
Dated: November 29, 2018. the Merchant Marine Personnel CFR 310 subpart A. To be eligible, you
Melanie J. Pantoja, Advisory Committee, Commandant must be jointly recommended by such
Program Analyst, Office of Federal Advisory (CG–MMC–1)/MERPAC, U.S. Coast state maritime academies.
Committee Policy. Guard, 2703 Martin Luther King Jr. Ave Each member will be appointed as
[FR Doc. 2018–26386 Filed 12–4–18; 8:45 am] SE, Stop 7509, Washington, DC 20593– Representative, and are not appointed in
BILLING CODE 4140–01–P 7509.
their individual capacity.
FOR FURTHER INFORMATION CONTACT: Mr.
Davis J. Breyer, Alternate Designated The Department of Homeland
DEPARTMENT OF HOMELAND Federal Officer of the Merchant Marine Security does not discriminate in the
SECURITY Personnel Advisory Committee, selection of Committee members on the
Commandant, (CG–MMC–1)/MERPAC, basis of race, color, religion, sex,
Coast Guard U.S. Coast Guard, 2703 Martin Luther national origin, political affiliation,
King Jr. Ave SE, Stop 7509, Washington, sexual orientation, gender identity,
[Docket No. USCG–2018–0876]
DC 20593–7509, telephone 202–372– marital status, disabilities and genetic
Merchant Marine Personnel Advisory 1445, fax 202–372–8382 or davis.j. information, age, membership in an
Committee; Vacancies breyer@uscg.mil. employee organization, or any other
non-merit factor. The Department of
AGENCY: U.S. Coast Guard, Department SUPPLEMENTARY INFORMATION: The
Homeland Security strives to achieve a
of Homeland Security. Merchant Marine Personnel Advisory
widely diverse candidate pool for all of
ACTION: Request for applications. Committee is a federal advisory
committee established in accordance its recruitment actions.
SUMMARY: The U.S. Coast Guard seeks with the provisions of the Federal If you are interested in applying to
applications for membership on the Advisory Committee Act (Title 5 U.S.C. become a member of the Committee,
Merchant Marine Personnel Advisory Appendix) and 46 U.S.C. 8108. send your cover letter and resume to Mr.
Committee. This Committee acts solely The Committee meets at least twice Davis J. Breyer, Alternate Designated
in an advisory capacity to the Secretary each year. Its subcommittees and Federal Officer of the Merchant Marine
of the Department of Homeland Security working groups may hold additional Personnel Advisory Committee via one
through the Commandant of the U.S. meetings as needed to consider specific of the transmittal methods in the
Coast Guard on matters relating to tasks. ADDRESSES section by the deadline in
personnel in the United States merchant Each Committee member serves a the DATES section of this notice. All
marine, including training, term of office of up to three years. email submittals will receive email
qualifications, certification, Members may serve a maximum of two
khammond on DSK30JT082PROD with NOTICES
receipt confirmations.
documentation, and fitness standards consecutive terms. All members serve at Dated: November 29, 2018.
and other matters as assigned by the their own expense and receive no salary
Commandant. The Committee advises, or other compensation from the Federal Jeffrey G. Lantz,
consults with, and makes Government. Members may be Director of Commercial Regulations and
recommendations reflecting its reimbursed for travel and per diem in Standards.
independent judgment to the Secretary accordance with Federal Travel [FR Doc. 2018–26420 Filed 12–4–18; 8:45 am]
and may make available to Congress Regulations. BILLING CODE 9110–04–P
VerDate Sep<11>2014 20:35 Dec 04, 2018 Jkt 247001 PO 00000 Frm 00044 Fmt 4703 Sfmt 4703 E:\FR\FM\06DEN1.SGM 06DEN1](https://thefederalregister.org/doc/83_FR_63109/page/2.svg)
Document Created: 2018-12-05 02:36:36
Document Modified: 2018-12-05 02:36:36
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Dates | February 11-12, 2019. | |
| FR Citation | 83 FR 62875 |
2024 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR